The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
The role of CD40 and CD154/CD40L in dendritic cells
Open accessAbstract
In this review, we focus on the function of CD40-CD40L (CD154) interactions in the regulation of dendritic cell (DC)-T cell and DC-B cell crosstalk. In addition, we examine differences and similarities between the CD40 signaling pathway in DCs and other innate immune cell receptors, and how these pathways integrate DC functions. As research into DC vaccines and immunotherapies progresses, further understanding of CD40 and DC function will advance the applicability of DCs in immunotherapy for human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Engagement of CD40 with its ligand induces recruitment of TNF receptor-associated factor family of proteins (TRAFs) and initiates signaling cascades that activate genes involved in cytokine production, as well as upregulation of co-stimulatory molecules such as CD80 and CD86 (37).”
From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., & Cerutti, A. (2002) · Nature Immunology · doi:10.1038/ni829 · Cited by 1,252
RetractedBettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Signaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,468
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature reviews. Immunology · doi:10.1038/nri746 · Cited by 2,289
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P. J. L., Lanzavecchia, A., & Alber, G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.747 · Cited by 1,982
Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation
Rissoan, M., Soumelis, V., Kadowaki, N., Grouard, G., Brière, F., Malefyt, R. D. W., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.283.5405.1183 · Cited by 1,835
CX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M. L., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,646
Cited by
Sorted by citations
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Tumour-intrinsic resistance to immune checkpoint blockade
Kalbasi, A. K., & Ribas, A. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0218-4 · Cited by 1,525
Dendritic cell-based immunotherapy
Sabado, R. L., Balan, S., & Bhardwaj, N. (2016) · Cell Research · doi:10.1038/cr.2016.157 · Cited by 942
Miao, L., Li, L., Huang, Y., Delcassian, D., Chahal, J., Han, J., Shi, Y., Sadtler, K., Gao, W., Lin, J., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0247-3 · Cited by 723
Stearns-Kurosawa, D. J., Osuchowski, M. F., Valentine, C., Kurosawa, S., & Remick, D. G. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130327 · Cited by 596
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2018) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 529
The present and future of bispecific antibodies for cancer therapy
Klein, C., Brinkmann, U., Reichert, J. M., & Kontermann, R. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00896-6 · Cited by 528
Therapeutic developments in pancreatic cancer
Hu, Z., & O'Reilly, E. M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00840-w · Cited by 438
IL-10: A Multifunctional Cytokine in Viral Infections
Rojas, J. M., Avia, M., Martı́n, V., & Sevilla, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/6104054 · Cited by 428
Mechanisms regulating T-cell infiltration and activity in solid tumors
Lanitis, E., Dangaj, D., Irving, M., & Coukos, G. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx238 · Cited by 369
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.005 · Cited by 335
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
Saxena, M., & Bhardwaj, N. (2018) · Trends in cancer · doi:10.1016/j.trecan.2017.12.007 · Cited by 307
Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
Hayashi, K., Nikolos, F., Lee, Y. C., Jain, A., Tsouko, E., Gao, H., Kasabyan, A., Leung, H. E., Osipov, A., Jung, S. Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19970-9 · Cited by 282
Targeting co-stimulatory molecules in autoimmune disease
Edner, N. M., Carlesso, G., Rush, J. S., & Walker, L. S. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0081-9 · Cited by 232
In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf
Hammerich, L., Binder, A. F., & Brody, J. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.016 · Cited by 188
The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
Aloui, C., Prigent, A., Sut, C., Tariket, S., Hamzeh‐Cognasse, H., Pozzetto, B., Richard, Y., Cognasse, F., Laradi, S., & Garraud, O. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151222342 · Cited by 186
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment
Nirschl, C. J., Suárez‐Fariñas, M., Izar, B., Prakadan, S. M., Dannenfelser, R., Tirosh, I., Liu, Y., Zhu, Q., Devi, K. S. P., Carroll, S. L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.016 · Cited by 183
Zander, R., Kasmani, M. Y., Yao, C., Topchyan, P., Shen, J., Zheng, S., Burns, R., Ingram, J. T., Cui, C., Joshi, N. S., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.018 · Cited by 143
The RANK–RANKL–OPG System: A Multifaceted Regulator of Homeostasis, Immunity, and Cancer
León-Oliva, D. D., Barrena-Blázquez, S., Jiménez-Álvarez, L., Fraile‐Μartinez, O., Montero, C. G., López-González, L., Torres‐Carranza, D., García-Puente, L. M., Carranza, S. T., Álvarez-Mon, M. Á., et al. (2023) · Medicina · doi:10.3390/medicina59101752 · Cited by 153
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
Yu, X., Orr, C. M., Chan, H. T. C., James, S., Penfold, C. A., Kim, J., Inzhelevskaya, T., Mockridge, C. I., Cox, K. L., Essex, J. W., et al. (2023) · Nature · doi:10.1038/s41586-022-05673-2 · Cited by 119
Differential B‐lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1
Graham, J. P., Arcipowski, K. M., & Bishop, G. A. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00932.x · Cited by 106
Engaging innate immunity in HIV-1 cure strategies
Nathan L. Board, Moskovljevic, M., Wu, F., Siliciano, R. F., & Siliciano, J. D. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00649-1 · Cited by 100
Sexual dimorphism in skin immunity is mediated by an androgen-ILC2-dendritic cell axis
Chi, L., Liu, C., Gribonika, I., Gschwend, J., Corral, D., Han, S., Lim, A. I., Rivera, C. A., Link, V. M., Wells, A. C., et al. (2024) · Science · doi:10.1126/science.adk6200 · Cited by 109
Molecular mechanisms of dendritic cell migration in immunity and cancer
de Winde, C. M., Munday, C., & Acton, S. E. (2020) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00680-4 · Cited by 104
The contextual role of TNFR family members in CD 8+ T‐cell control of viral infections
Wortzman, M. E., Clouthier, D., McPherson, A. J., Lin, G. H. Y., & Watts, T. H. (2013) · Immunological Reviews · doi:10.1111/imr.12086 · Cited by 99
Hang, L., Setiawan, T., Blum, A. M., Urban, J. F., Stoyanoff, K. M., Arihiro, S., Reinecker, H., & Weinstock, J. V. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000941 · Cited by 91
T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword
Simons, K. H., de Jong, A., Jukema, J. W., de Vries, M. R., Arens, R., & Quax, P. H. A. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0164-7 · Cited by 89
Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients
Groß, S., Erdmann, M., Haendle, I., Voland, S., Berger, T. G., Schultz, E. S., Strasser, E. F., Dankerl, P., Janka, R., Schliep, S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91438 · Cited by 89
Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis
Lee, E. S., Sul, J. H., Shin, J. M., Shin, S., Lee, J. A., Kim, H. K., Cho, Y. E., Ko, H., Son, S., Lee, J., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.026 · Cited by 88
Wolff, C. M., Singer, D., Schmidt, A., & Bekeschus, S. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132194 · Cited by 92
Bihl, F., Pecheur, J., Bréart, B., Poupon, G., Cazareth, J., Julia, V., Glaichenhaus, N., & Braud, V. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001486 · Cited by 93
Cuevas-Cianca, S. I., Romero-Castillo, C., Gálvez-Romero, J. L., Juárez, Z. N., & Hernández, L. R. (2023) · Molecules · doi:10.3390/molecules28031488 · Cited by 88
CD40-Mediated Activation of the NF-κB2 Pathway
Hostager, B. S., & Bishop, G. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00376 · Cited by 90
Sittplangkoon, C., Alameh, M.-G., Weissman, D., Lin, P. J. C., Tam, Y. K., Prompetchara, E., & Palaga, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983000 · Cited by 79
“Engagement of CD40 with its ligand induces recruitment of TNF receptor-associated factor family of proteins (TRAFs) and initiates signaling cascades that activate genes involved in cytokine production, as well as upregulation of co-stimulatory molecules such as CD80 and CD86 (37).”
BackgroundInfluentialImmunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells
Bourque, J., & Hawiger, D. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026790 · Cited by 79
CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes
HASKINS, K. M., & Cooke, A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.004 · Cited by 78
Ozeri, E., Mizrahi, M. I., Shahaf, G., & Lewis, E. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101340 · Cited by 75
Hashem, A. M., Algaissi, A. A., Agrawal, A. S., Alamri, S. S., Alhabbab, R. Y., Sohrab, S. S., Almasoud, A. S., Alharbi, N. K., Peng, B., Russell, M. S., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz137 · Cited by 72
Dakal, T. C., Dhabhai, B., Agarwal, D., Gupta, R., Nagda, G., Meena, A. R., Dhakar, R., Menon, A. M., Mathur, R., Mona, M., et al. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.151899 · Cited by 74
Escape from X chromosome inactivation and female bias of autoimmune diseases
Mousavi, M. J., Mahmoudi, M., & Ghotloo, S. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00256-1 · Cited by 81
The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation
Samy, K. P., Butler, J. R., Li, P., Cooper, D. K. C., & Ekser, B. (2017) · Journal of Immunology Research · doi:10.1155/2017/8415205 · Cited by 74
Multiple effects of CD40–CD40L axis in immunity against infection and cancer
Ara, A., Ahmed, K. A., & Xiang, J. (2018) · ImmunoTargets and Therapy · doi:10.2147/itt.s163614 · Cited by 77
A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy
Zhang, L., Xu, L., Wang, Y., Liu, J., Tan, G., Huang, F., He, N., & Lu, Z. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.01.071 · Cited by 73
Deciphering sex differences in the immune system and depression
Rainville, J. R., Tsyglakova, M., & Hodes, G. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.12.004 · Cited by 73
Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity
Yu, X., Chan, H. T. C., Fisher, H., Penfold, C. A., Kim, J., Inzhelevskaya, T., Mockridge, C. I., French, R. R., Duriez, P. J., Douglas, L. R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.013 · Cited by 74
Regulation by SIRPα of dendritic cell homeostasis in lymphoid tissues
Saito, Y., Iwamura, H., Kaneko, T., Ohnishi, H., Murata, Y., Okazawa, H., Kanazawa, Y., Sato‐Hashimoto, M., Kobayashi, H., Oldenborg, P., et al. (2010) · Blood · doi:10.1182/blood-2010-03-277244 · Cited by 72
TNF receptor family signaling in the development and functions of medullary thymic epithelial cells
Akiyama, T., Shinzawa, M., & Akiyama, N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00278 · Cited by 70
Zhang, N., Li, J., Hu, Y., Cheng, G., Zhu, X., Liu, F., Zhang, Y., Liu, Z., & Xu, J. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.05.030 · Cited by 70
Li, P. Y., Bearoff, F. M., Zhu, P., Fan, Z., Zhu, Y., Fan, M., Cort, L., Kambayashi, T., Blankenhorn, E. P., & Cheng, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.013 · Cited by 70
The Non-Hemostatic Aspects of Transfused Platelets
Sut, C., Tariket, S., Aubron, C., Aloui, C., Hamzeh‐Cognasse, H., Berthelot, P., Laradi, S., Greinacher, A., Garraud, O., & Cognasse, F. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00042 · Cited by 73
Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines
Viswanath, D. I., Liu, H., Huston, D. P., Chua, C. Y. X., & Grattoni, A. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121297 · Cited by 72
Qiu, H. X., Wu, H., Chan, V. S. F., Lau, C.-S., & Lu, Q. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1284821 · Cited by 69
Zhang, J. Q., Zeng, S., Vitiello, G. A., Seifert, A. M., Medina, B. D., Beckman, M. J., Loo, J. K., Santamaria‐Barria, J. A., Maltbaek, J. H., Param, N. J., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0345 · Cited by 70
Cao, M., Deng, Y., Hao, Q., Yan, H., Wang, Q., Dong, C., Wu, J., He, Y., Huang, L., Xia, X., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02226-7 · Cited by 76
Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines
Leroux-Roels, G. G., Leroux‐Roels, I., Clément, F., Ofori‐Anyinam, O., Lievens, M., Jongert, E., Moris, P., Ballou, W. R., & Cohen, J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29375 · Cited by 66
Liu, Y., Cook, C. P., Sedgewick, A. J., Zhang, S., Fassett, M. S., Ricardo-González, R. R., Harirchian, P., Kashem, S. W., Hanakawa, S., Leistico, J. R., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101582 · Cited by 61
Jenabian, M., Patel, M., Kema, I. P., Vyboh, K., Kanagaratham, C., Radzioch, D., Thébault, P., Lapointe, R., Gilmore, N. J., Ancuța, P., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12396 · Cited by 65
Unique Sjögren’s syndrome patient subsets defined by molecular features
James, J. A., Guthridge, J. M., Chen, H., Lu, R., Bourn, R. L., Bean, K. M., Munroe, M. E., Smith, M. C., Chakravarty, E. F., Baer, A. N., et al. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez335 · Cited by 65
Nahar, U. J., Tóth, I., & Skwarczyński, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.038 · Cited by 65
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Bödder, J., Zahan, T., van Slooten, R., Schreibelt, G., de Vries, I. J. M., & Flórez‐Grau, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.631713 · Cited by 67
RANKL-RANK interaction in immune regulatory systems
Akiyama, T. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i9.142 · Cited by 65
Martín‐Gayo, E., Cronin, J., Hickman, T. L., Ouyang, Z., Lindqvist, M., Kolb, K. E., Wiesch, J. S. Z., Cubas, R. A., Porichis, F., Shalek, A. K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89574 · Cited by 63
Regulation of T cell-associated tissues and T cell activation by RANKL-RANK-OPG
Walsh, M. C., & Choi, Y. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01178-y · Cited by 62
Leroux‐Roels, I., Devaster, J., Leroux-Roels, G. G., Verlant, V., Henckaerts, I., Moris, P., Hermand, P., Belle, P. V., POOLMAN, J. T., Vandepapelière, P., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.052 · Cited by 62
Ando, K., Fujita, H., Hosoi, A., Ma, L., Wakatsuki, M., Seino, K., Kakimi, K., Imai, T., Shimokawa, T., & Nakano, T. (2017) · Journal of Radiation Research · doi:10.1093/jrr/rrx005 · Cited by 62
Saccharomyces cerevisiae (Baker’s Yeast) as an Interfering RNA Expression and Delivery System
Duman‐Scheel, M. (2018) · Current Drug Targets · doi:10.2174/1389450120666181126123538 · Cited by 62
Toll-like receptors in mediating pathogenesis in systemic sclerosis
Frasca, L., & Lande, R. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13426 · Cited by 59
T-cell-independent Antitumor Effects of CD40 Ligation
Rakhmilevich, A. L., Alderson, K. L., & Sondel, P. M. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.698337 · Cited by 56
Bene, K., Varga, Z., Petrov, V. O., Boyko, N., & Rajnavölgyi, É. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00427 · Cited by 57
Plasmacytoid dendritic cells drive acute asthma exacerbations
Chairakaki, A.-D., Saridaki, M.-I., Pyrillou, K., Mouratis, M.-A., Koltsida, O., Walton, R. P., Bartlett, N. W., Stavropoulos, A., Boon, L., Rovina, N., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.032 · Cited by 54
Pfeffer, P., Ho, T.-R., Mann, E. H., Kelly, F. J., Sehlstedt, M., Pourazar, J., Dove, R. E., Sandström, T., Mudway, I., & Hawrylowicz, C. M. (2017) · Immunology · doi:10.1111/imm.12852 · Cited by 53
Th-1 Lymphocytes Induce Dendritic Cell Tumor Killing Activity by an IFN-γ–Dependent Mechanism
LaCasse, C. J., Janikashvili, N., Larmonier, C. B., Alizadeh, D., Hanke, N. T., Kartchner, J., Situ, E., Centuori, S. M., Har-Noy, M., Bonnotte, B., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101812 · Cited by 53
Kajikawa, A., Nordone, S. K., Zhang, L., Stoeker, L. L., LaVoy, A. S., Klaenhammer, T. R., & Dean, G. A. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05153-11 · Cited by 55
Corneth, O. B. J., de Bruijn, M. J. W., Rip, J., Asmawidjaja, P. S., Kil, L. P., & Hendriks, R. W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600208 · Cited by 53
Nanoplastic impact on bone microenvironment: A snapshot from murine bone cells
Giannandrea, D., Parolini, M., Citro, V., Felice, B. D., Pezzotta, A., Abazari, N., Platonova, N., Sugni, M., Chiu, M., Villa, A. M., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132717 · Cited by 51
Ando, Y., Yasuoka, C., Mishima, T., Ikematsu, T., Uede, T., Matsunaga, T., & Inobe, M. (2013) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-013-9705-2 · Cited by 51
Schneider-Ohrum, K., Giles, B. M., Weirback, H. K., Williams, B. L., DeAlmeida, D. R., & Ross, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.051 · Cited by 50
Emerging Canonical and Non-Canonical Roles of Granzyme B in Health and Disease
Tibbs, E. J., & Cao, X. (2022) · Cancers · doi:10.3390/cancers14061436 · Cited by 52
Mamuti, M., Wang, Y., Zhao, Y., Wang, J., Wang, J., Fan, Y., Xiao, W., Hou, D., Yang, J., Zheng, R., et al. (2022) · Advanced Materials · doi:10.1002/adma.202109432 · Cited by 49
Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses
Melchers, M., Bontjer, I., Tong, T., Chung, N. P. Y., Klasse, P. J., Eggink, D., Montefiori, D. C., Gentile, M., Cerutti, A., Olson, W. C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06259-11 · Cited by 48
Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity
Calderwood, S. K., Murshid, A., & Gong, J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00075 · Cited by 49
Romano, M., Sollazzo, D., Trabanelli, S., Barone, M., Polverelli, N., Perricone, M., Forte, D., Luatti, S., Cavo, M., Vianelli, N., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1345402 · Cited by 48
Next-generation therapies for pancreatic cancer
Buckley, C. W., & O'Reilly, E. M. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2322648 · Cited by 49
Datta, J., Berk, E., Cintolo, J. A., Xu, S., Roses, R. E., & Czerniecki, B. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00271 · Cited by 47
Вячеславовна, А. Е., Popova, L. I., Zamyatnin, A. A., Werner, J. M., Mikhailovsky, N. V., & Bazhin, A. V. (2021) · Vaccines · doi:10.3390/vaccines9111363 · Cited by 45
Mechanisms of NK cell activation: CD4+ T cells enter the scene
Bihl, F., Germain, C., Luci, C., & Braud, V. M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0796-1 · Cited by 45
Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy
Schoenhals, J. E., Seyedin, S. N., Tang, C. Z., Cortez, M. A., Niknam, S., Tsouko, E., Chang, J. Y., Hahn, S. M., & Welsh, J. W. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000181 · Cited by 46
Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants
Berzi, A., Ordanini, S., Joosten, B., Trabattoni, D., Cambi, A., Bernardi, A., & Clerici, M. (2016) · Scientific Reports · doi:10.1038/srep35373 · Cited by 44
Tsoumakidou, M., Tousa, S., Semitekolou, M., Panagiotou, P., Panagiotou, A., Morianos, I., Litsiou, E., Trochoutsou, A. I., Konstantinou, M., Potaris, Κ., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.045 · Cited by 43
Yoshino, Y., Roy, B., Kumar, N., Mukhtar, M. S., & Dwivedi, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01159-9 · Cited by 44
Costimulation Blockade in Kidney Transplantation
Malvezzi, P., Jouvé, T., & Rostaing, L. P. E. (2016) · Transplantation · doi:10.1097/tp.0000000000001344 · Cited by 41
Ramachandran, M., Jin, C., Yu, D., Eriksson, F., & Essand, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400339 · Cited by 41
Tumor Necrosis Factor Receptor/Tumor Necrosis Factor Family Members in Antiviral CD8 T-Cell Immunity
Salek‐Ardakani, S., & Croft, M. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0026 · Cited by 41
Immunity to Cryptosporidium: Lessons from Acquired and Primary Immunodeficiencies
Cohn, I. S., Henrickson, S. E., Striepen, B., & Hunter, C. A. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200512 · Cited by 39
Jenberie, S., Thim, H. L., Sunyer, J. O., Skjødt, K., Jensen, I., & Jørgensen, J. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-21895-9 · Cited by 40
Qian, C., Li, Q., Yu, Y., An, H., Guo, Z., Han, Y., Chen, Y., Bai, Y., Wang, Q., & Cao, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.425751 · Cited by 39
Human dendritic cell immunodeficiencies
Bigley, V., Cytlak, U., & Collin, M. P. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.02.020 · Cited by 41
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
Smith, K. E., Deronic, A., Hägerbrand, K., Norlén, P., & Ellmark, P. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1934446 · Cited by 38
Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade
O’Reilly, D. P., Murphy, C. A., Drew, R. J., EL-Khuffash, A. F., Maguire, P. B., Áinle, F. N., & Callion, N. M. (2021) · Pediatric Research · doi:10.1038/s41390-021-01715-z · Cited by 45
Absence of Annexin A1 impairs host adaptive immunity against Mycobacterium tuberculosis in vivo
Koh, V. H. Q., Julia, M. G., Lin, W., Michelle, A. L. T., Zarina, Z. R. S., Lina, L. H. K., & Alonso, S. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.12.001 · Cited by 38
Metadata
- Authors
- Ma, D. Y., & Clark, E. A.
- Corresponding author
- Clark, Edward A.
- ORCID
- Clark, Edward A.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 21
- Issue
- 5
- Pages
- 265-272
- ISSN
- 1044-5323 (ISSN-L)
- PMC
- PMC2749083
- OpenAlex
- W1968783338
- Cited by
- 446
- References
- 131
- Citations by year
- 2026: 20 · 2025: 34 · 2024: 32 · 2023: 36 · 2022: 26 · 2021: 43 · 2020: 36 · 2019: 24 · 2018: 31 · 2017: 27 · 2016: 20 · 2015: 21 · 2014: 19 · 2013: 15 · 2012: 18
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Seminars in Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM037905)
- National Institute of Allergy and Infectious Diseases (AI-52203, R37AI044257, R01AI052203)
- National Institute of Dental and Craniofacial Research (DE16381, R01DE016381)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- CD40, dendritic cells, innate immune receptors, dendritic cell vaccine, immunotherapy
- MeSH terms
- Animals, B-Lymphocytes, Cell Communication, Dendritic Cells, Humans, T-Lymphocytes, Signal Transduction, CD40 Antigens, Receptor Cross-Talk, CD40 Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review